全文获取类型
收费全文 | 261306篇 |
免费 | 56682篇 |
国内免费 | 11288篇 |
专业分类
耳鼻咽喉 | 3505篇 |
儿科学 | 6737篇 |
妇产科学 | 2537篇 |
基础医学 | 33012篇 |
口腔科学 | 8350篇 |
临床医学 | 34291篇 |
内科学 | 47114篇 |
皮肤病学 | 9777篇 |
神经病学 | 20805篇 |
特种医学 | 9637篇 |
外国民族医学 | 68篇 |
外科学 | 32865篇 |
综合类 | 36477篇 |
现状与发展 | 50篇 |
一般理论 | 47篇 |
预防医学 | 19307篇 |
眼科学 | 5641篇 |
药学 | 24400篇 |
192篇 | |
中国医学 | 13759篇 |
肿瘤学 | 20705篇 |
出版年
2024年 | 651篇 |
2023年 | 2546篇 |
2022年 | 6466篇 |
2021年 | 9740篇 |
2020年 | 11424篇 |
2019年 | 15474篇 |
2018年 | 15459篇 |
2017年 | 16650篇 |
2016年 | 17110篇 |
2015年 | 20041篇 |
2014年 | 21878篇 |
2013年 | 22859篇 |
2012年 | 20034篇 |
2011年 | 21034篇 |
2010年 | 21142篇 |
2009年 | 15692篇 |
2008年 | 14124篇 |
2007年 | 12486篇 |
2006年 | 11905篇 |
2005年 | 10071篇 |
2004年 | 7462篇 |
2003年 | 6979篇 |
2002年 | 5939篇 |
2001年 | 4827篇 |
2000年 | 3944篇 |
1999年 | 2769篇 |
1998年 | 1362篇 |
1997年 | 1270篇 |
1996年 | 991篇 |
1995年 | 899篇 |
1994年 | 717篇 |
1993年 | 473篇 |
1992年 | 634篇 |
1991年 | 568篇 |
1990年 | 490篇 |
1989年 | 421篇 |
1988年 | 348篇 |
1987年 | 364篇 |
1986年 | 297篇 |
1985年 | 238篇 |
1984年 | 160篇 |
1983年 | 146篇 |
1982年 | 94篇 |
1981年 | 86篇 |
1979年 | 122篇 |
1978年 | 69篇 |
1977年 | 74篇 |
1974年 | 91篇 |
1973年 | 85篇 |
1972年 | 64篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
纸夹板内收位固定与石膏外展位固定治疗Bennett骨折的随机对照试验 总被引:2,自引:0,他引:2
目的:研究比较纸夹板内收位固定与石膏外展位固定治疗Bennett骨折的疗效差异。方法:选择2005年10月至2007年4月门诊就诊的70例Bennett骨折患者,按区组随机的方法分为试验组35例(纸夹板内收位固定)和对照组35例(石膏外展位固定)进行治疗。骨折达到临床愈合拆除固定后,对患者进行为期6个月的随访观察。分别于骨折后6、8、12、16、20及24周按改良的Gabriele评分系统对其患手功能进行量化评分比较。结果:两组的优良率在8、12、16及20周时比较试验组优于对照组,差异有统计学意义(P〈0.05);6周和24周时比较差异无统计学意义(P〉0.05)。两组在功能评分方面,8、12、16、20及24周时比较试验组高于对照组,差异有统计学意义(P〈0.05);6周时积分差异无统计学意义(P〉0.05)。结论:在Bennett骨折的治疗中,纸夹板内收位固定与石膏外展位固定相比能明显加快患手功能的恢复,而且固定轻便、舒适,患者易于接受,可以作为一种有效的固定方法在临床推广。 相似文献
102.
A conjugate of antisense oligodeoxynucleotide (AS ODN) covalently linked with deoxorubicin (DOX) was synthesized. Its properties and antitumour activity in human carcinoma DOX resistant cells (KB-A-1) were investigated in vitro. The results showed that the conjugate was strongly stable both in Dulbecco's Phosphate-Buffered Saline (PBS) and in culture medium. The intracellular concentration of the conjugate was higher than that of the AS DON by HPLC analysis. The conjugate showed potent dose-dependent inhibition to the growth of KB-A-1 cells. Chemosensitivity of KB-A-1 cells to DOX was also investigated in vitro. When the cells were first exposed to the conjugate (0.5 microM) and then exposed to DOX for 24 h, the IC50 value of DOX decreased from 21.5 to 2.2 microM. In contrast, when treated with the mixture of the same concentration of the AS ODN with equivalent DOX, the IC50 value of DOX was 16.8 microM. Intracellular DOX concentration was detected in KB-A-1 treatment with the conjugate in vitro by HPLC. The results showed that the intracellular DOX concentration was 6.4-fold increased in KB-A-1 cells treated with the conjugate compared to treatment with DOX alone. In contrast, 1.8-fold increasing was observed when treated with the AS ODN. Western blot analysis showed a significantly decrease in the amount of P-glycoprotein in KB-A-1 cells. These results suggest that the conjugate is effective in reversing multidrug resistance. Certainly, further studies are conducting to explore the antitumour effect of the conjugate in vivo. 相似文献
103.
Eric Lim Ziad Ali Ayyaz Ali Reza Motalleb-Zadeh Christopher Jackson Seok Ling Ong James Halstead Linda Sharples Jayan Parameshwar John Wallwork Stephen R Large 《The Journal of heart and lung transplantation》2005,24(8):983-989
BACKGROUND: To ascertain survival of ischemic advanced heart failure patients by treatment allocation, we examined the outcome of transplant assessment patients allocated to medical therapy, high-risk conventional surgery, or transplantation. METHODS: Patients were identified from the Papworth transplant database and excluded if primary etiology was not ischemic. Grouping was undertaken according to treatment allocation at initial assessment, and analysis was performed by intention to treat. Survival was computed from the time of assessment and Cox regression used to stratify patients according risk with the Heart Failure Survival Score. RESULTS: From May 1993 to September 2001, a total of 755 patients were admitted for transplant assessment, with 348 (46.1%) identified as having heart failure of ischemic origin. Variables required for calculation of the Heart Failure Survival Score was available in 273 patients (78.4%), and 20 patients (7.3%) were lost to follow-up. Of the remaining 253 patients, 89 (35.2%) were allocated to medical therapy, 32 (12.6%) to surgery, and 132 (52.2%) to transplantation. The relative risk (95% confidence limit) of death compared with medical therapy was 0.62 (0.28, 1.40) for surgery and 0.38 (0.24, 0.61) for transplantation in medium- to high-risk patients. For low-risk patients, the relative risks for death compared with medical therapy were 1.87 (0.63, 5.60) for surgery and 1.97 (0.79, 4.96) for transplantation. CONCLUSIONS: Transplantation improved survival of medium- and high-risk patients compared with medical therapy. In the low-risk group, this was not evident. However, repeated assessment of risk is required because the hazard for death rises steadily after the third year in these patients. 相似文献
104.
目的 对单纯行裂隙关闭术和同期行咽后壁咽成形术的大龄腭裂患者,术前、术后发音效果进行检测分析和对比研究,评定手术的治疗效果.方法 对24例同期行腭裂关闭术及咽后壁组织瓣咽成形术治疗和12例单纯行裂隙关闭术的大龄腭裂患者,术前、术后用鼻咽纤维镜检测其腭咽闭合情况,应用通用音频谱分析系统,对本组术后患者腭裂语音进行声学分析.结果 所有腭裂修复术后,创口均达到临床Ⅰ期愈合,语音也有不同程度改善.大龄腭裂患者采用腭裂关闭及同期咽成形术的修复组,术后发音明显优于单纯行裂隙关闭组.结论 大龄腭裂患者,采用腭裂关闭及同期咽成形术,是提高腭咽闭合和改善发音较好的手术方法. 相似文献
105.
改良开放性手术治疗巨大良性前列腺增生症 总被引:2,自引:0,他引:2
目的探讨巨大良性前列腺增生症的开放性手术治疗方法及效果。方法回顾分析16例巨大良性前列腺增生症,年龄61~88岁,平均74岁。作耻骨上经膀胱前列腺切除术。结果手术均成功;手术时间35~65min,出血量100~200mL,术后前列腺重量为200~520g,平均215g;膀胱冲洗2~3d,拔导尿管5~7d;术后3d再出血1例,经DSA同侧髂内血管栓塞止血成功,排尿困难1例,短期尿失禁1例,其余患者术后均排尿通畅,控尿良好。结论开放性手术治疗巨大良性前列腺增生症,其梗阻解除彻底,是一种合理的治疗方法。恰当的手术方法是提高疗效及降低并发症的关键。 相似文献
106.
107.
Cardiac imaging in the evaluation of patients presenting to the emergency department with chest pain
Conclusions Despite the utility and benefits that each imaging modality has to offer, it is easy to see why there is still no perfect
choice for a noninvasive cardiac imaging modality to assist in the management of chest pain patients. All of the current imaging
techniques have their own significant strengths and weaknesses when compared with other modalities. SPECT and echocardiography
are wellestablished technologies that can directly assess the presence of myocardial ischemia and its functional consequence
on RF; newer and more expensive techniques such as MDCT and CMR can directly assess coronary anatomy and have just started
to be evaluated in the acute chest pain setting. There are no studies that directly compare these technologies, and more data
are clearly needed before the question of whether anatomic imaging versus perfusion/function imaging is the better approach
can be answered. Other comparisons such as relative safety, availability, logistics, and cost-effectiveness between the various
technologies are also lacking.
Of all of the imaging modalities discussed, MCE is the only portable technology. The images do not require expensive software
or other technology for offline processing before interpretation, and any trained cardiologist can read the study at the bedside
or, potentially, over the Internet, providing near-instantaneous results in the acute cardiac setting, where time is of the
essence.
MCE is also relatively cheap compared with other technologies, a potential advantage for payors but not necessarily for payees.
How reimbursement rates and fee structures eventually affect clinical practice is also unknown.
Despite these and other questions that need to be answered before any one technique will be used exclusively, the future of
noninvasive cardiac imaging remains an exciting and ever-changing field. The adaptation of any one of these techniques into
its proper role in the ED Journal of Nuclear Cardiology Wyrick and Wei 753 Volume 13, Number 6;749-55 Cardiac imaging in patients
with chest pain will take considerably more time and effort in terms of research, money, and time-tested clinical experience. 相似文献
108.
泰素蒂加顺铂治疗进展期NSCLC的临床研究 总被引:5,自引:0,他引:5
目的观察泰素蒂加顺铂方案治疗进展期非小细胞肺癌的临床疗效、毒副作用。方法收集可评价疗效的进展期非小细胞肺癌50例,以泰素蒂加顺铂方案进行化疗,泰素蒂75 mg/m2静脉滴注,第1天;顺铂25 mg/m2~30 mg/m2静脉滴注,第2天~第5天,每3周为一个周期,2~3周期后评价疗效和毒副反应并随访。结果50例患者中,总有效率为50.0 %,其中初治病例为53.1 %,复治病例为44.4 %,初复治病例间差异无显著性(P >0.05)。中位缓解期为5个月。中位生存期为9.5个月,1年生存率为61.0 %。毒副反应主要为骨髓抑制,白细胞下降达Ⅲ度、Ⅳ度者52.0 %,血小板下降达Ⅲ度、Ⅳ度者为14.0 %。血红蛋白下降不严重。其他毒副反应还有脱发、过敏反应、水钠潴留、静脉炎、末梢神经炎、口腔炎、腹泻等,但发生率均较低。结论泰素蒂加顺铂方案治疗进展期非小细胞肺癌,特别是复发病例,临床疗效比较满意,毒副反应能够耐受。辅以G蛳CSF可防治重度的骨髓抑制,有较好的临床应用价值。 相似文献
109.
目的 总结和评价经直肠超声引导下前列腺穿刺活检术对前列腺癌诊断的准确率。方法 222 例直肠指检阳性或 PSA>4μg/L的患者应用经直肠超声引导下前列腺6点系统穿刺活检以明确诊断。结果 222 例受检者中病理证实前列腺结节性增生41例、前列腺炎24例、前列腺肉瘤3例、前列腺癌 154 例,其中低分化癌 74 例、中分化癌 58 例、高分化癌 22 例。术后血尿15例、发热6例,其中高热1例,经抗生素治疗后体温恢复正常、尿检阴性。结论 经直肠超声引导下前列腺穿刺活检无需麻醉,患者痛苦小、安全性高,是诊断前列腺癌的可靠方法。 相似文献
110.
目的:探讨腹腔内注射沙培林增强人腹腔抗癌免疫功能的机制。方法:72例早中期胃肠道肿瘤患者术前48h和24h腹腔内分别注射生理盐水和5KE的沙培林,术中采集腹腔内巨噬细胞,计数并测定乳酸脱氢酶(LDH)和酸性磷酸酶(ACP)的活性,巨噬细胞吞噬活力,一氧化氮(NO)的分泌以及对人胃癌MKN1细胞的细胞毒性进行分析。同时采集大网膜,对大网膜乳斑的数量和面积进行观察。结果:沙培林显著增加腹腔巨噬细胞(PMΦ)的数量和NO的分泌,增强LDH和ACP的活性,吞噬活力,以及抗癌细胞毒性,也显著增加了大网膜乳斑的数量和面积。结论:腹腔内注射沙培林可显著增加人大网膜乳斑的数量和面积,并因此增加PMΦ的数量,增强PMΦ的活性。因而增强了腹腔巨噬细胞的免疫功能。 相似文献